BACKGROUND: Postural tachycardia syndrome (POTS) is a disorder characterized by excessive orthostatic tachycardia and significant functional disability. We previously reported that POTS patients have low blood volume and inappropriately low plasma renin activity (PRA) and aldosterone. In this study, we sought to more fully characterize the renin-angiotensin-aldosterone system (RAAS) to gain a better understanding of the pathophysiology of POTS. OBJECTIVE: The purpose of this study was to prospectively assess the plasma levels of angiotensin (Ang) peptides and their relationship to other RAAS components in patients with POTS compared with healthy controls. METHODS: Heart rate, PRA, Ang I, Ang II, Ang (1-7), and aldosterone were measured in POTS patients (n = 38) and healthy controls (n = 13) while they were consuming a sodium-controlled diet. RESULTS: POTS patients had larger orthostatic increases in heart rate than did controls (52 ± 3 [mean ± SEM] bpm vs 27 ± 6 bpm, P = .001). Plasma Ang II was significantly higher in POTS patients (43 ± 3 pg/mL vs 28 ± 3 pg/mL, P = .006), whereas plasma Ang I and angiotensin 1-7 [Ang-(1-7)] were similar between groups. Despite the twofold increase of Ang II, POTS patients trended to lower PRA levels than did controls (0.9 ± 0.1 ng/mL/h vs 1.6 ± 0.5 ng/mL/h, P = .268) and lower aldosterone levels (4.6 ± 0.8 pg/mL vs 10.0 ± 3.0 pg/mL, P = .111). Estimated angiotensin-converting enzyme-2 (ACE2) activity was significantly lower in POTS patients than in controls (0.25 ± 0.02 vs 0.33 ± 0.03, P = .038). CONCLUSION: Some patients with POTS have inappropriately high plasma Ang II levels, with low estimated ACE2 activity. We propose that these abnormalities in Ang regulation may play a key role in the pathophysiology of POTS in some patients.
BACKGROUND:Postural tachycardia syndrome (POTS) is a disorder characterized by excessive orthostatic tachycardia and significant functional disability. We previously reported that POTSpatients have low blood volume and inappropriately low plasma renin activity (PRA) and aldosterone. In this study, we sought to more fully characterize the renin-angiotensin-aldosterone system (RAAS) to gain a better understanding of the pathophysiology of POTS. OBJECTIVE: The purpose of this study was to prospectively assess the plasma levels of angiotensin (Ang) peptides and their relationship to other RAAS components in patients with POTS compared with healthy controls. METHODS: Heart rate, PRA, Ang I, Ang II, Ang (1-7), and aldosterone were measured in POTSpatients (n = 38) and healthy controls (n = 13) while they were consuming a sodium-controlled diet. RESULTS:POTSpatients had larger orthostatic increases in heart rate than did controls (52 ± 3 [mean ± SEM] bpm vs 27 ± 6 bpm, P = .001). Plasma Ang II was significantly higher in POTSpatients (43 ± 3 pg/mL vs 28 ± 3 pg/mL, P = .006), whereas plasma Ang I and angiotensin 1-7 [Ang-(1-7)] were similar between groups. Despite the twofold increase of Ang II, POTSpatients trended to lower PRA levels than did controls (0.9 ± 0.1 ng/mL/h vs 1.6 ± 0.5 ng/mL/h, P = .268) and lower aldosterone levels (4.6 ± 0.8 pg/mL vs 10.0 ± 3.0 pg/mL, P = .111). Estimated angiotensin-converting enzyme-2 (ACE2) activity was significantly lower in POTSpatients than in controls (0.25 ± 0.02 vs 0.33 ± 0.03, P = .038). CONCLUSION: Some patients with POTS have inappropriately high plasma Ang II levels, with low estimated ACE2 activity. We propose that these abnormalities in Ang regulation may play a key role in the pathophysiology of POTS in some patients.
Authors: N Muenter Swift; N Charkoudian; R M Dotson; G A Suarez; P A Low Journal: Am J Physiol Heart Circ Physiol Date: 2005-04-29 Impact factor: 4.733
Authors: R G Dluhy; S Z Bavli; F K Leung; H S Solomon; T J Moore; N K Hollenberg; G H Williams Journal: J Clin Invest Date: 1979-11 Impact factor: 14.808
Authors: Hossam I Mustafa; Satish R Raj; André Diedrich; Bonnie K Black; Sachin Y Paranjape; William D Dupont; Gordon H Williams; Italo Biaggioni; David Robertson Journal: Circ Arrhythm Electrophysiol Date: 2012-01-13
Authors: Qi Fu; Tiffany B Vangundy; Shigeki Shibata; Richard J Auchus; Gordon H Williams; Benjamin D Levine Journal: Hypertension Date: 2011-06-20 Impact factor: 10.190
Authors: Rocío A Figueroa; Amy C Arnold; Victor C Nwazue; Luis E Okamoto; Sachin Y Paranjape; Bonnie K Black; Andre Diedrich; David Robertson; Italo Biaggioni; Satish R Raj; Alfredo Gamboa Journal: J Appl Physiol (1985) Date: 2014-07-24
Authors: Ashley L Wagoner; Hossam A Shaltout; John E Fortunato; Debra I Diz Journal: Am J Physiol Heart Circ Physiol Date: 2015-11-25 Impact factor: 4.733